Doctors test re-engineered immune cells to fight tough bladder cancers
NCT ID NCT05768347
Summary
This is an early-stage study testing a new cell therapy for people with a specific type of bladder cancer that has come back after standard treatment. Researchers collect a patient's own immune cells from their tumor, grow more of them in a lab, and then put them back into the bladder. The main goal is to see if this process is safe and tolerable for patients, while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.